Discover 951 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 951
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Eugene OR, Reno NV, Napa CA, Santa Monica CA,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
Patient Retrospective Outcomes (PRO)
for
Chronic Pain
Location: Eugene OR, Medford OR, Larkspur CA, Idaho Falls ID,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT01550575
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
for
Pain
Location: Eugene OR, Regina, Greenwood Village CO, Shreveport LA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT01719055
Recruiting
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
for
Depression
Location: Springfield OR
Sponsor: Oregon Research Institute
Sex: All
Age: 2+
Code: NCT05142384
Recruiting
A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment
for
Mild Cognitive Impairment, Accidental Falls, Aging
Location: Springfield OR
Sponsor: Oregon Research Institute
Sex: All
Age: 65 - 70+
Code: NCT05725668
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults
for
Accidental Fall
Location: Springfield OR
Sponsor: Oregon Research Institute
Sex: All
Age: 65 - 70+
Code: NCT05822466
Recruiting
Walk With Me (WWM) for Perinatal Grief
for
Grief, Post Traumatic Stress Disorder, Suicidal Ideation,
Location: Eugene OR
Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.
Sex: All
Age: 15+
Code: NCT07011940
Recruiting
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
for
Teacher Self-efficacy for Teaching PE, Teacher PE Instruction,
Location: Springfield OR, Eugene OR
Sponsor: Saavsus, Inc.
Sex: All
Age: 7+
Code: NCT07203313
Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Springfield OR, Silverdale WA, Bellevue WA,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase3, Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for
Prostate Cancer
Location: Springfield OR, San Luis Obispo CA, Los Angeles CA,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06952803
Phase3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Springfield OR, Silverdale WA, Bellevue WA,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase3, Recruiting
FeaturedActive & Responsive
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
for
Mid Face Volume Deficit
Location: Portland OR, San Diego CA, Glendale AZ, Austin TX,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT06734351
Phase3, Recruiting
FeaturedActive & Responsive
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
for
Bipolar I or II Disorder
Location: Portland OR, Bellevue WA, Everett WA, Walnut Creek CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07220460
Phase2, Recruiting
Featured
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for
Atopic Dermatitis
Location: Portland OR, Boise ID, Reno NV, Greenbrae CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 63
Code: NCT06389136
Phase3, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: Portland OR, Spokane WA, Reno NV, Sacramento CA,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase3, Recruiting
Featured
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: Portland OR, Seattle WA, East Brunswick NJ,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07525206
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Portland OR, Los Angeles CA, Fullerton CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase2, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Location: Portland OR, Oklahoma City OK, Austin TX, Nashville TN,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07024784
Phase2, Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Salem OR, Tacoma WA, Seattle WA, Stockton CA,